Chris Pasquale

Stock Analyst at Guggenheim

(n/a)
# 4,345
Out of 4,667 analysts
6
Total ratings
n/a
Success rate
-28.27%
Average return

Stocks Rated by Chris Pasquale

ZimVie
Mar 18, 2022
Initiates: Neutral
Price Target: n/a
Current: $13.49
Upside: -
iCAD, Inc.
Jan 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $1.55
Upside: -
DexCom
Jan 7, 2022
Upgrades: Buy
Price Target: $145
Current: $75.24
Upside: +92.72%
The Cooper Companies
Jan 3, 2022
Upgrades: Buy
Price Target: $124
Current: $99.08
Upside: +24.90%
PROCEPT BioRobotics
Oct 11, 2021
Initiates: Buy
Price Target: $45
Current: $92.70
Upside: -51.46%